Table 1 The clinical characteristics of GSE17800 and recruited subjects
Type | Parameter | Control | DCM | p-value |
|---|---|---|---|---|
GSE17800 | Number | n = 8 | n = 40 | NA |
LVEF (%) | 60 (52, 64) | 35 (28, 39) |  < 0.001 | |
LVIDD (mm) | 51.4 ± 3.1 | 69.8 ± 8.0 |  < 0.001 | |
Gender (female) | 2 (25%) | 12 (30%) | 1.0 | |
Age (years) | 44 (30, 57) | 52 (42, 58) | 0.213 | |
Virus (negative) | 8 (100%) | 18 (45%) | 0.005 | |
Inflammation | 10 (8, 13) | 18 (12, 22) | 0.001 | |
BMI (Kg/m2) | 25.0 (23.1, 29.3) | 27 (24, 30) | 0.306 | |
Recruited subjects | Number | n = 6 | n = 8 | NA |
LVEDV (ml) | 87.4 ± 14.6 | 248.3 ± 81.4 |  < 0.001 | |
LVESV (ml) | 29.7 ± 7.1 | 177.6 ± 71.0 |  < 0.001 | |
EF (%) | 66.5 ± 2.9 | 30.2 ± 14.3 |  < 0.001 | |
LVIDD (mm) | 45.0 ± 4.0 | 70.5 ± 8.7 |  < 0.001 | |
Age | 54.6 ± 10.8 | 57.9 ± 8.8 | 0.579 | |
Gender (Male) | 2 (40%) | 5 (55.6%) | 1.0 |